{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T08:02:47Z","timestamp":1784707367739,"version":"3.55.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi di Modena e Reggio Emilia"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Percutaneous pericardiocentesis is the standard diagnostic and therapeutic procedure for severe pericardial effusion (PE). While its procedural safety has improved over time, data on long-term outcomes in cancer patients remain limited. We aim to evaluate clinical outcomes after pericardiocentesis, with a specific focus on neoplastic-related PE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We collected data of patients who underwent percutaneous pericardiocentesis at the University Hospital of Modena, between December 2006 and September 2025. Patients were stratified into three groups: neoplastic, idiopathic, and other specific etiologies. The primary endpoint was all-cause mortality, while the secondary endpoint was a composite of in-hospital adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 179 patients were included (median age 72, 39.7% women). Major procedural-related complications occurred in 4.5% of patients, while in-hospital mortality was 15.6%. During a mean follow-up of 15.8\u00a0months, 44.1% of patients died. Mortality was significantly higher in patients with neoplastic PE (61.1%) compared with those with other etiologies (44.9%) and idiopathic PE (23.4%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001). Neoplastic etiology was independently associated with an increased risk of death compared with idiopathic PE (aHR 5.22, 95% CI 2.41\u201311.35).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study showed that percutaneous pericardiocentesis is an effective and safe procedure, with a major complication rate consistent with contemporary series across variable etiologies. Despite similar procedural safety, patients with neoplastic PE experienced markedly worse long-term outcomes linked to the underlying malignancy rather than the procedure itself. In oncological patients, pericardiocentesis should be contextualized within the overall oncological trajectory, balancing procedural benefit with patient prognosis and individual treatment goals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                    <jats:p>Percutaneous pericardiocentesis in cancer and noncancer patients. Legend: aHR, adjusted hazard ratio (analysis adjusted for age, coronary artery disease, and hemodynamic instability); CI, confidence interval; PE, pericardial effusion.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00392-026-02981-9","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T07:32:34Z","timestamp":1784705554000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term mortality and acute complications after percutaneous pericardiocentesis in cancer and noncancer patients presenting with severe pericardial effusion"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5196-6249","authenticated-orcid":false,"given":"Marco","family":"Vitolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Bagnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio A.","family":"Sgura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Arrotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Monopoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo F.","family":"Imberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide A.","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Bonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Dominici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Lopez-Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Boriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"2981_CR1","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.tcm.2018.10.016","volume":"29","author":"PR Sinnaeve","year":"2019","unstructured":"Sinnaeve PR, Adriaenssens T (2019) A contemporary look at pericardiocentesis. Trends Cardiovasc Med 29:375\u2013383","journal-title":"Trends Cardiovasc Med"},{"key":"2981_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2459\/JCM.0000000000000649","volume":"19","author":"S Maggiolini","year":"2018","unstructured":"Maggiolini S, De Carlini CC, Imazio M (2018) Evolution of the pericardiocentesis technique. J Cardiovasc Med (Hagerstown) 19:267\u2013273","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"2981_CR3","first-page":"102","volume":"10","author":"M Imazio","year":"2020","unstructured":"Imazio M, De Ferrari GM (2020) Cardiac tamponade: an educational review. Eur Heart J Acute Cardiovasc Care 10:102\u2013109","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2981_CR4","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1093\/eurheartj\/ehaf192","volume":"46","author":"J Schulz-Menger","year":"2025","unstructured":"Schulz-Menger J, Collini V, Gr\u00f6schel J, Adler Y, Brucato A, Christian V et al (2025) 2025 ESC guidelines for the management of myocarditis and pericarditis. Eur Heart J 46:3952\u20134041","journal-title":"Eur Heart J"},{"issue":"25","key":"2981_CR5","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1016\/j.jacc.2025.05.023","volume":"86","author":"TKM Wang","year":"2025","unstructured":"Wang TKM, Klein AL, Cremer PC, Imazio M, Kohnstamm S, Luis SA et al (2025) Concise clinical guidance: An ACC expert consensus statement on the diagnosis and management of pericarditis: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol 86(25):2691\u20132719. https:\/\/doi.org\/10.1016\/j.jacc.2025.05.023","journal-title":"J Am Coll Cardiol"},{"key":"2981_CR6","first-page":"1121","volume":"39","author":"G Lazaros","year":"2023","unstructured":"Lazaros G, Imazio M, Tsioufis P, Lazarou E, Vlachopoulos C, Tsioufis C (2023) Chronic pericardial effusion: causes and management. Can J Cardiol 39:1121\u20131131","journal-title":"Can J Cardiol"},{"key":"2981_CR7","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.jacc.2015.06.1332","volume":"66","author":"D El Haddad","year":"2015","unstructured":"El Haddad D, Iliescu C, Yusuf Syed W, William William N, Khair Tarif H, Song J et al (2015) Outcomes of cancer patients undergoing percutaneous pericardiocentesis for pericardial effusion. JACC 66:1119\u20131128","journal-title":"JACC"},{"key":"2981_CR8","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.007598","author":"A Strobbe","year":"2017","unstructured":"Strobbe A, Adriaenssens T, Bennett J, Dubois C, Desmet W, McCutcheon K et al (2017) Etiology and long-term outcome of patients undergoing pericardiocentesis. J Am Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.117.007598","journal-title":"J Am Heart Assoc"},{"key":"2981_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euaf109","author":"J Zhou","year":"2025","unstructured":"Zhou J, Li D, Wang L, Duan J, Ze F, Yuan C et al (2025) Procedural outcomes of transvenous lead extraction in patients with abandoned leads: experience from a large single centre. Europace. https:\/\/doi.org\/10.1093\/europace\/euaf109","journal-title":"Europace"},{"key":"2981_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euaf254","author":"S Bordignon","year":"2025","unstructured":"Bordignon S, Mills MT, Futyma P, Sultan A, Metzner A, Migliore F et al (2025) European Heart Rhythm Association survey on the perceived severity of complications in atrial fibrillation ablation: development of a standardized scoring model. Europace. https:\/\/doi.org\/10.1093\/europace\/euaf254","journal-title":"Europace"},{"issue":"6","key":"2981_CR11","doi-asserted-by":"publisher","first-page":"831","DOI":"10.33963\/v.phj.110950","volume":"84","author":"B Szl\u00f3sarczyk","year":"2026","unstructured":"Szl\u00f3sarczyk B, Mo\u0142ek-Dziadosz P, Eliasz K, Krawczyk K, Bany\u015b P, Miszalski-Jamka T (2026) Multimodal imaging in post-infarction pericarditis: echocardiography versus cardiac magnetic resonance imaging in distinguishing haemorrhagic from inflammatory pericardial complications. Pol Heart J (Kardiol Pol) 84(6):831\u2013832. https:\/\/doi.org\/10.33963\/v.phj.110950","journal-title":"Pol Heart J (Kardiol Pol)"},{"key":"2981_CR12","doi-asserted-by":"publisher","first-page":"220","DOI":"10.33963\/v.kp.96608","volume":"82","author":"A Sufryd","year":"2024","unstructured":"Sufryd A, Kubicius A, Mizia-Stec K, Wybraniec M (2024) Acute purulent pericarditis complicated by cardiac tamponade in a patient with human immunodeficiency virus. Polish Heart Journal (Kardiologia Polska) 82:220\u2013221","journal-title":"Polish Heart Journal (Kardiologia Polska)"},{"key":"2981_CR13","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejim.2024.01.024","volume":"123","author":"E Conte","year":"2024","unstructured":"Conte E, Tamanini S, Bizzi E, Maestroni S, Cumetti D, Novembre ML et al (2024) Post-cardiac injury syndrome and pericardial effusion recurrence after pericardial effusion drainage in chronic idiopathic pericardial effusion. Eur J Intern Med 123:132\u2013137","journal-title":"Eur J Intern Med"},{"key":"2981_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16203466","author":"L Lorenzo-Esteller","year":"2024","unstructured":"Lorenzo-Esteller L, Ramos-Polo R, Pons Riverola A, Morillas H, Berdejo J, Pernas S et al (2024) Pericardial disease in patients with cancer: clinical insights on diagnosis and treatment. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers16203466","journal-title":"Cancers (Basel)"},{"key":"2981_CR15","first-page":"8","volume":"10","author":"S Mori","year":"2024","unstructured":"Mori S, Bertamino M, Guerisoli L, Stratoti S, Canale C, Spallarossa P et al (2024) Pericardial effusion in oncological patients: current knowledge and principles of management. Cardiooncology 10:8","journal-title":"Cardiooncology"},{"key":"2981_CR16","doi-asserted-by":"publisher","first-page":"131","DOI":"10.33963\/v.phj.109247","volume":"84","author":"K Styczkiewicz","year":"2026","unstructured":"Styczkiewicz K, Lewicka E, Bielecka-D\u0105browa A, G\u0142\u00f3wczy\u0144ska R, Banach M, Leszek P et al (2026) Principles of primary prevention of cardiovascular diseases in patients with cancer. Expert opinion of the Working Group on Prevention and Epidemiology (Cardio-oncology Task Force) and the Working Group on Cardio-oncology of the Polish Cardiac Society. Pol Heart J 84:131\u2013156","journal-title":"Pol Heart J"},{"key":"2981_CR17","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.jacc.2015.07.027","volume":"66","author":"TSM Tsang","year":"2015","unstructured":"Tsang TSM (2015) Echocardiography-guided pericardiocentesis for effusions in patients with cancer revisited. J Am Coll Cardiol 66:1129\u20131131","journal-title":"J Am Coll Cardiol"},{"key":"2981_CR18","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.jcmg.2024.04.010","volume":"17","author":"AL Klein","year":"2024","unstructured":"Klein AL, Wang TKM, Cremer PC, Abbate A, Adler Y, Asher C et al (2024) Pericardial diseases. JACC Cardiovasc Imaging 17:937\u2013988","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"2981_CR19","doi-asserted-by":"publisher","first-page":"euad378","DOI":"10.1093\/europace\/euad378","volume":"26","author":"A Metzner","year":"2024","unstructured":"Metzner A, Sultan A, Futyma P, Richter S, Perrotta L, Chun KRJ (2024) Prevention and treatment of pericardial tamponade in the electrophysiology laboratory: a European Heart Rhythm Association survey. EP Europace 26(1):euad378. https:\/\/doi.org\/10.1093\/europace\/euad378","journal-title":"EP Europace"},{"key":"2981_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2025.06.005","author":"E Ceriani","year":"2025","unstructured":"Ceriani E, Schiavon R, La Cava L, Ruscitti C, Cogliati C (2025) Point of care ultrasound: focus on evidence for a critical appraisal. Eur J Intern Med. https:\/\/doi.org\/10.1016\/j.ejim.2025.06.005","journal-title":"Eur J Intern Med"},{"key":"2981_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol32090514","author":"JY Bae","year":"2025","unstructured":"Bae JY, Park DY, Banna S, Hu JR, Saleh A, Mamas MA et al (2025) In-hospital mortality among patients undergoing percutaneous pericardiocentesis for pericardial effusion with and without malignancy. Curr Oncol. https:\/\/doi.org\/10.3390\/curroncol32090514","journal-title":"Curr Oncol"},{"key":"2981_CR22","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s11739-018-1907-x","volume":"13","author":"A Brucato","year":"2018","unstructured":"Brucato A, Imazio M, Cremer PC, Adler Y, Maisch B, Lazaros G et al (2018) Recurrent pericarditis: still idiopathic? The pros and cons of a well-honoured term. Intern Emerg Med 13:839\u2013844","journal-title":"Intern Emerg Med"},{"key":"2981_CR23","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1093\/eurheartj\/ehv051","volume":"36","author":"H Thiele","year":"2015","unstructured":"Thiele H, Ohman EM, Desch S, Eitel I, de Waha S (2015) Management of cardiogenic shock. Eur Heart J 36:1223\u20131230","journal-title":"Eur Heart J"},{"key":"2981_CR24","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/ejhf.478","volume":"18","author":"VP Harjola","year":"2016","unstructured":"Harjola VP, Mebazaa A, \u010celutkien\u0117 J, Bettex D, Bueno H, Chioncel O et al (2016) Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology. Eur J Heart Fail 18:226\u2013241","journal-title":"Eur J Heart Fail"},{"key":"2981_CR25","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","volume":"41","author":"SV Konstantinides","year":"2020","unstructured":"Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP et al (2020) 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J 41:543\u2013603","journal-title":"Eur Heart J"},{"issue":"105","key":"2981_CR26","first-page":"S117","volume":"2024","author":"KDIGO","year":"2024","unstructured":"KDIGO (2024) clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 2024(105):S117-s314","journal-title":"Kidney Int"},{"key":"2981_CR27","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.jacc.2016.05.068","volume":"68","author":"C Iliescu","year":"2016","unstructured":"Iliescu C, Khair T, Marmagkiolis K, Iliescu G, Durand JB (2016) Echocardiography and fluoroscopy-guided pericardiocentesis for cancer patients with cardiac tamponade and thrombocytopenia. J Am Coll Cardiol 68:771\u2013773","journal-title":"J Am Coll Cardiol"},{"key":"2981_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000368796","volume":"130","author":"MY Ho","year":"2015","unstructured":"Ho MY, Wang JL, Lin YS, Mao CT, Tsai ML, Wen MS et al (2015) Pericardiocentesis adverse event risk factors: a nationwide population-based cohort study. Cardiology 130:37\u201345","journal-title":"Cardiology"},{"key":"2981_CR29","first-page":"1251","volume":"15","author":"K Salem","year":"1999","unstructured":"Salem K, Mulji A, Lonn E (1999) Echocardiographically guided pericardiocentesis - the gold standard for the management of pericardial effusion and cardiac tamponade. Can J Cardiol 15:1251\u20131255","journal-title":"Can J Cardiol"},{"key":"2981_CR30","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1053\/euje.1999.0003","volume":"1","author":"F Vayre","year":"2000","unstructured":"Vayre F, Lardoux H, Pezzano M, Bourdarias JP, Dubourg O (2000) Subxiphoid pericardiocentesis guided by contrast two-dimensional echocardiography in cardiac tamponade: experience of 110 consecutive patients. Eur J Echocardiogr 1:66\u201371","journal-title":"Eur J Echocardiogr"},{"key":"2981_CR31","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S0025-6196(11)62211-8","volume":"77","author":"TS Tsang","year":"2002","unstructured":"Tsang TS, Enriquez-Sarano M, Freeman WK, Barnes ME, Sinak LJ, Gersh BJ et al (2002) Consecutive 1127 therapeutic echocardiographically guided pericardiocenteses: clinical profile, practice patterns, and outcomes spanning 21 years. Mayo Clin Proc 77:429\u2013436","journal-title":"Mayo Clin Proc"},{"key":"2981_CR32","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1046\/j.1365-2796.2003.01103.x","volume":"253","author":"M Lindenberger","year":"2003","unstructured":"Lindenberger M, Kjellberg M, Karlsson E, Wranne B (2003) Pericardiocentesis guided by 2-D echocardiography: the method of choice for treatment of pericardial effusion. J Intern Med 253:411\u2013417","journal-title":"J Intern Med"},{"key":"2981_CR33","first-page":"234","volume":"23","author":"R Inglis","year":"2011","unstructured":"Inglis R, King AJ, Gleave M, Bradlow W, Adlam D (2011) Pericardiocentesis in contemporary practice. J Invasive Cardiol 23:234\u2013239","journal-title":"J Invasive Cardiol"},{"issue":"Suppl 2","key":"2981_CR34","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00059-014-4187-x","volume":"40","author":"S Akyuz","year":"2015","unstructured":"Akyuz S, Zengin A, Arugaslan E, Yazici S, Onuk T, Ceylan US et al (2015) Echo-guided pericardiocentesis in patients with clinically significant pericardial effusion. Outcomes over a 10-year period. Herz 40(Suppl 2):153\u2013159","journal-title":"Herz"},{"key":"2981_CR35","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.amjcard.2016.01.043","volume":"117","author":"S Maggiolini","year":"2016","unstructured":"Maggiolini S, Gentile G, Farina A, De Carlini CC, Lenatti L, Meles E et al (2016) Safety, efficacy, and complications of pericardiocentesis by real-time echo-monitored procedure. Am J Cardiol 117:1369\u20131374","journal-title":"Am J Cardiol"},{"key":"2981_CR36","first-page":"451","volume":"65","author":"I Battistoni","year":"2017","unstructured":"Battistoni I, Marini M, Angelini L, Francioni M, Gili A, Moretti S et al (2017) Safety and efficacy of non-continuous echocardiography-guided pericardiocentesis: a single-center study of 478 patients. Minerva Cardioangiol 65:451\u2013457","journal-title":"Minerva Cardioangiol"},{"key":"2981_CR37","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s44156-025-00071-6","volume":"12","author":"V Zarama","year":"2025","unstructured":"Zarama V, Vesga CE, Balanta-Silva J, Barbosa MM, Quintero JA, Clarete A et al (2025) Complication rates in real-time ultrasound-guided vs static echocardiography-guided pericardiocentesis: a cohort study. Echo Res Pract 12:8","journal-title":"Echo Res Pract"},{"key":"2981_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/medicina61020265","author":"DS Simeunovi\u0107","year":"2025","unstructured":"Simeunovi\u0107 DS, Milinkovi\u0107 I, Polovina M, Trifunovi\u0107 Zamaklar D, Velji\u0107 I, Zaharijev S et al (2025) Safety and efficacy of echo- vs. fluoroscopy-guided pericardiocentesis in cardiac tamponade. Medicina (Kaunas). https:\/\/doi.org\/10.3390\/medicina61020265","journal-title":"Medicina (Kaunas)"},{"key":"2981_CR39","doi-asserted-by":"publisher","first-page":"490","DOI":"10.2459\/JCM.0000000000001766","volume":"26","author":"M Biolcati","year":"2025","unstructured":"Biolcati M, Mauro A, Del Furia F, Corsi DC, Tassistro E, Lettino M (2025) Efficacy and safety of apical access in percutaneous pericardiocentesis: a comparison with subxiphoid approach. J Cardiovasc Med (Hagerstown) 26:490\u2013498","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"2981_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14144985","author":"RK Qasba","year":"2025","unstructured":"Qasba RK, Cangut B, Alhazmi A, Naseer J, Mubasher A, Talapaneni S et al (2025) Surgical management strategies for pericardial effusion-a systematic review. J Clin Med. https:\/\/doi.org\/10.3390\/jcm14144985","journal-title":"J Clin Med"},{"key":"2981_CR41","volume":"13","author":"LP Vemireddy","year":"2021","unstructured":"Vemireddy LP, Jain N, Aqeel A, Jeelani HM, Shayuk M (2021) Lung adenocarcinoma presenting as malignant pericardial effusion\/tamponade. Cureus 13:e13762","journal-title":"Cureus"},{"key":"2981_CR42","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s11936-018-0654-7","volume":"20","author":"AK Ghosh","year":"2018","unstructured":"Ghosh AK, Crake T, Manisty C, Westwood M (2018) Pericardial disease in cancer patients. Curr Treat Options Cardiovasc Med 20:60","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"2981_CR43","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.cjco.2024.05.003","volume":"6","author":"SE Mudra","year":"2024","unstructured":"Mudra SE, Rayes D, Kumar AK, Li JZ, Njus M, McGowan K et al (2024) Malignant pericardial effusion: a systematic review. CJC Open 6:967\u2013972","journal-title":"CJC Open"},{"key":"2981_CR44","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1007\/s11739-021-02642-x","volume":"16","author":"A Pennacchioni","year":"2021","unstructured":"Pennacchioni A, Nanni G, Sgura FA, Imberti JF, Monopoli DE, Rossi R et al (2021) Percutaneous pericardiocentesis for pericardial effusion: predictors of mortality and outcomes. Intern Emerg Med 16:1771\u20131777","journal-title":"Intern Emerg Med"},{"key":"2981_CR45","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.jaccao.2025.06.008","volume":"7","author":"K Miteva","year":"2025","unstructured":"Miteva K, Anker MS, Fechner H, Lehmann L, Van Linthout S (2025) Cancer-related immune therapies. JACC CardioOncol 7:523\u2013537","journal-title":"JACC CardioOncology"},{"key":"2981_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2025.134000","volume":"445","author":"V Collini","year":"2026","unstructured":"Collini V, Vignut LS, Venturelli F, Imazio M (2026) Drug-induced pericarditis: a systematic review of all published cases. Int J Cardiol 445:134000","journal-title":"Int J Cardiol"},{"key":"2981_CR47","first-page":"475","volume":"6","author":"DG Gent","year":"2024","unstructured":"Gent DG, Saif M, Dobson R, Wright DJ (2024) Cardiovascular disease after hematopoietic stem cell transplantation in adults. JACC: CardioOncol 6:475\u2013495","journal-title":"JACC: CardioOncol"},{"key":"2981_CR48","first-page":"781","volume":"7","author":"HS Raman","year":"2025","unstructured":"Raman HS, Mitchell J, Nohria A, Upshaw JN, LaCasce AS (2025) Cardiovascular and oncologic considerations in adult Hodgkin lymphoma. JACC: CardioOncol 7:781\u2013799","journal-title":"JACC: CardioOncol"},{"key":"2981_CR49","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jaccao.2019.07.001","volume":"1","author":"A Besnard","year":"2019","unstructured":"Besnard A, Raoux F, Khelil N, Monin JL, Saal JP, Veugeois A et al (2019) Current management of symptomatic pericardial effusions in cancer patients. JACC CardioOncology 1:137\u2013140","journal-title":"JACC CardioOncology"},{"key":"2981_CR50","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.035549","volume":"13","author":"F Sahiti","year":"2024","unstructured":"Sahiti F, Cejka V, Schmidbauer L, Albert J, Kerwagen F, Frantz S et al (2024) Prognostic utility of pericardial effusion in the general population: findings from the STAAB cohort study. J Am Heart Assoc 13:e035549","journal-title":"J Am Heart Assoc"},{"key":"2981_CR51","first-page":"191","volume":"7","author":"U Rao Vijay","year":"2025","unstructured":"Rao Vijay U, Deswal A, Lenihan D, Dent S, Lopez-Fernandez T, Lyon Alexander R et al (2025) Quality-of-care measures for cardio-oncology JACC: CardioOncology 7:191\u2013202","journal-title":"Quality-of-care measures for cardio-oncology JACC: CardioOncology"},{"key":"2981_CR52","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/S0002-9149(02)03408-2","volume":"91","author":"TS Tsang","year":"2003","unstructured":"Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB (2003) Outcomes of clinically significant idiopathic pericardial effusion requiring intervention. Am J Cardiol 91:704\u2013707","journal-title":"Am J Cardiol"},{"key":"2981_CR53","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"43","author":"AR Lyon","year":"2022","unstructured":"Lyon AR, L\u00f3pez-Fern\u00e1ndez T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J et al (2022) 2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): developed by the task force on cardio-oncology of the European Society of Cardiology (ESC). Eur Heart J 43:4229\u20134361","journal-title":"Eur Heart J"},{"key":"2981_CR54","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.jaccao.2023.06.002","volume":"5","author":"MG Fradley","year":"2023","unstructured":"Fradley MG, Wilcox N, Frain I, Rao VU, Carver J, Guha A et al (2023) Developing a clinical cardio-oncology program and the building blocks for success: JACC: CardioOncology how to. JACC CardioOncol 5:707\u2013710","journal-title":"JACC CardioOncol"},{"key":"2981_CR55","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2025.4543","author":"J Herrmann","year":"2025","unstructured":"Herrmann J, Barac A, Carver J, Cheng RK, Daniele A, Dent S et al (2025) Immune checkpoint inhibitor-associated cardiovascular toxic effects: International Cardio-Oncology Society position statement. JAMA Oncol. https:\/\/doi.org\/10.1001\/jamaoncol.2025.4543","journal-title":"JAMA Oncol"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-026-02981-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-026-02981-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-026-02981-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T07:32:36Z","timestamp":1784705556000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-026-02981-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":55,"alternative-id":["2981"],"URL":"https:\/\/doi.org\/10.1007\/s00392-026-02981-9","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"22 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the local Ethics Committee, and the study was performed in accordance with the European Union Note for Guidance on Good Clinical Practice (CPMP\/ECH\/135\/95) and the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"GB is the Principal Investigator of the ARISTOTELES project (applying artificial intelligence to define clinical trajectories for personalized prediction and early detection of comorbidity and multimorbidity patterns) that received funding from the European Union within the Horizon 2020 research and innovation program (Grant N. 101080189) and reports small speaker fees from Bayer, Boehringer Ingelheim, Boston, BMS, Daiichi, Sanofi, and Janssen outside the submitted work. All other authors report no disclosures.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}